Blood Transfusion Diagnostics Market Analysis

  • Report ID: 4481
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Blood Transfusion Diagnostics Market Analysis

Application (Blood Group Typing, Blood Screening)

The blood transfusion diagnostics market is segmented and analyzed for demand and supply by application into blood group typing and blood screening. Out of the two, the blood screening segment is anticipated to hold the largest market size by the end of 2037. Rising blood donations and transfusions are likely to boost the growth of the segment. By the statistics of the WHO, about 119 million of blood is donated every year all around the world. In addition, the growing penetration of sexually transmitted diseases, hepatitis B, and HIV are driving the segment’s growth. According to the Centers for Disease Control and Prevention, around 296 million people are living with hepatitis B worldwide. Moreover, as per the World Health Organization, the prevalence of STDs has impacted more than 1 million people all over the world.

End-user (Hospital Based Laboratories, Blood Banks)

The global blood transfusion diagnostics market is also segmented and analyzed for demand and supply by end-user in hospital-based laboratories and blood banks. Out of these segments, hospital-based laboratories are projected to secure a higher market share by 2037. This can be owed to the fact that hospital-based laboratories are better equipped to conduct the complicated and crucial screening procedures necessary for blood transfusions since they are furnished with cutting-edge machinery and technology and operated by qualified personnel. Additionally, these labs are in a good position to provide patients with a variety of diagnostic services such as blood typing. Also, hospitals are expanding their diagnostic capabilities to satisfy the rising need for blood products as the demand for blood transfusions rises. For instance, it was found that there were about 6100 hospitals in the U.S. in 2022.

Our in-depth analysis of the global market includes the following segments:

      By Product Type

  • Instruments
  • Reagents & Kits

       By Application

  • Blood Group Typing
  • Blood Screening

        By End-User

  • Hospital Based Laboratories
  • Blood Banks
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4481
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of blood transfusion diagnostics is estimated at USD 4.58 billion.

The blood transfusion diagnostics market size was over USD 4.31 billion in 2024 and is anticipated to cross USD 7.09 billion by 2037, growing at more than 3.9% CAGR during the forecast period i.e., between 2025-2037. Growing cases of COVID-19, rising road accidents, a dearth of blood donations, and a higher number suffering from kidney issues and chronic disease will boost the market growth.

North America industry is poised to account for largest revenue share of 41% by 2037, driven by higher number of road accidents taking place in the region.

The major players in the market are Immucor, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Quotient Limited, Beckman Coulter, Inc., DiaSorin S.p.A., BD (Becton, Dickinson, and Company), Ortho Clinical Diagnostics, Grifols, S.A., Thermo Fisher Scientific Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample